Objective: Dilatation of the aorta within the proximal neck after endovascular aneurysm repair (EVAR) can be associated with late endoleaks and migration. This study was designed to identify predictors of early neck dilation in patients undergoing EVAR with Heli-FX EndoAnchors (Medtronic, Santa Rosa, Calif) measured perioperatively to 1 year at different longitudinal levels of neck length.
The introduction of endovascular aneurysm repair (EVAR) by Parodi et al 1 in 1991 revolutionized the treatment of aortic aneurysms. Despite reductions in morbidity and early mortality compared with open surgical aneurysm repair (OSR), the ultimate success and durability of EVAR is highly dependent on aneurysm morphology and, most importantly, proximal neck anatomy. Several characteristics of the proximal neck, including its length, angulation, and degree of circumferential thrombus and calcium, have been considered when defining aortic neck anatomy as "favorable" or "hostile." Patients with hostile neck anatomy are at apostolos.tassiopoulos@stonybrookmedicine.edu).
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Copyright Aneurysm sac diameter commonly decreases after EVAR when an adequate seal is achieved. 3, 4 Aortic neck dilatation (AND) has been described since the early years of EVAR and is observed in w20% of EVAR patients at 2 years. [4] [5] [6] The diameter increase noted between the preoperative and first postoperative imaging reflects changes that occur as the neck accommodates the outward radial force exerted by the endograft. Over time, the proximal neck diameter may continue to enlarge and eventually reach or exceed the nominal, fully expanded diameter of the endograft. Loss of endograft apposition occurs once the neck diameter exceeds that of the endograft, resulting in loss of seal, type Ia endoleak, and, in the absence of active fixation, endograft migration.
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The Aneurysm Treatment Using the Heli-FX Aortic Securement System (ANCHOR) Global Registry was created in 2012 to monitor longitudinally patients with unfavorable aortic neck anatomy who underwent EVAR with the use of Heli-FX EndoAnchors (Medtronic, Santa Rosa, Calif). 7 Unfavorable anatomy in the ANCHOR registry was defined as a neck with one or more of the following characteristics: neck length <10 mm, infrarenal aortic diameter >28 mm, neck angulation >60 , neck thrombus/calcium $2 mm average thickness, or neck thrombus/calcium $180 of neck circumference. Registry results have been published in subsequent publications. [8] [9] [10] The current study was designed to identify predictors of early AND at different aortic levels using the current ANCHOR database of patients with hostile neck anatomy.
METHODS
ANCHOR is a prospective, nonrandomized, dual-arm, multicenter, postmarket registry of the real-world use of the Heli-FX EndoAnchors system. ANCHOR was first registered on ClinicalTrials.gov on February 9, 2012 (NCT01534819). Institutional Review Board or Ethics Committee approval was obtained at each investigational site. The registry was conducted according to the Declaration of Helsinki and applicable sections of ISO 14155, MEDDEV 2.12-2, and the International Conference on Harmonization Good Clinical Practice guidelines. All patients enrolled in the registry gave written informed consents.
The current cohort was limited to 257 patients at 38 investigational sites in the United States and Europe. Patients underwent EndoAnchor implantation for prophylaxis against proximal neck complications or for treatment of a type Ia endoleak that was evident after endograft deployment. Mean duration of imaging follow-up was w1 year (mean, 11.9 6 4.0 months). Computed tomography (CT) imaging was available preoperatively and at 1 month for 209 patients, and 62 patients had completed CT imaging at both 1 and 12 months.
Imaging studies. Follow-up was performed according to the local standard of care at each enrolling institution. Independent core laboratory analyses (Syntactx, New York, NY) were performed on noncontrast and contrast CT imaging studies. Centerline reformatting and segmentation of CT data sets was performed using iNtuition imaging software (TeraRecon, Foster City, Calif). Measurements were done orthogonal to the flow lumen by different core laboratory technologists, and the average diameters were recorded. The aortic diameter was measured at three levels within the proximal neck: (1) "level 0" was at the lowest main renal artery, (2) "level 5" was 5 mm distal, and (3) "level 10" was 10 mm distal to the lowest main renal artery. Aortic diameter was also measured 20 mm proximal to the lowest main renal artery, defined as the suprarenal (SR) level.
The proximal aortic neck length was calculated as the length where the aortic diameter remained no more than 10% greater than the immediate infrarenal diameter. Infrarenal neck angulation was measured with centerline points at the level of the lowest renal artery, at the distal aortic neck, and at the aortic bifurcation. Aortic neck calcium and thrombus content was measured and expressed in degrees of circumference where its thickness was >1 mm. Significant mural thrombus or calcium was defined when the average thickness was >1 mm. For the purposes of analysis, the 1-year imaging study specified a window of 360 6 90 days.
Data analysis. The baseline diameter of the aorta at the specific sites from the preoperative CT was compared with the diameter at the same level on the 1-month and 12-month postoperative CT scans for each patient with available images at the specific time point. AND was expressed as the difference between the aortic neck diameters on the preoperative baseline and the 1-month and 12-month postoperative images. A positive number reflected neck dilatation (in mm) between baseline and postoperative images.
ARTICLE HIGHLIGHTS
Multivariable analyses were performed to identify independent predictors of early AND at each level. Candidate variables included six clinical and 14 anatomic variables. Eight models were run, one at each of the four aortic levels at each of the two time frames (from preoperative baseline to the 1-month imaging studies [ Table I ] and from the 1-month to the 1-year studies [ Table II] ). To reduce the effects of multicollinearity, independent variables with a Spearman r >0.7 were excluded from the multiple linear regression. Multiple linear regression models were developed for each of the two time frames. Models were developed for each of the four aortic levels at each time frame, resulting in eight regression models.
RESULTS
Among the 257 patients, 169 (65.8%) were treated with EndoAnchors for prophylaxis against proximal neck complications, and 88 (34.4%) were treated for immediate type Ia endoleaks after endograft deployment. The 196 male (76.3%) and 61 female (23.7%) patients were a mean age of 73.2 6 8.4 years (range, 50-97 years).
Aneurysm sac diameter averaged 56 6 10 mm. Preoperatively, the mean proximal neck length was 18 6 Diameter change in the perioperative period (preoperative to 1 month). The mean aortic neck enlargement between the preoperative baseline and 1-month CT images was 0.2 6 1.7 mm, 0.7 6 2.2 mm, and 0.9 6 3.6 mm at levels 0 mm, 5 mm, and 10 mm, respectively, and 0.0 6 1.5 mm at level SR. When a 3-mm threshold was used, aortic neck enlargement occurred in 5.3%, 12.5%, and 14.6% of patients at the three infrarenal levels, respectively, and in 1.9% of patients at level SR. Multiple regression models identified predictive variables for each of the four aortic levels (Table III) . At levels 0 mm and 5 mm, the use of an endograft without a suprarenal bare stent was associated with minimal neck diameter change. Larger baseline aortic neck diameters at the lowest renal artery were less frequently associated with neck diameter increases (protective effect) at levels 0, 5, and 10 but not at level SR. Necks containing mural calcium were less likely to exhibit diameter increases at level 10.
Diameter change from 1 month to 1 year. Between the 1-month and 12-month images, aortic neck diameter increased a mean of 0.5 6 1.6 mm, 0.4 6 1.5 mm, and 0.2 6 1.8 mm at levels 0, 5, and 10 mm, respectively, and decreased by a mean of 0.3 6 1.1 mm at level SR. When a 3-mm threshold was used, AND occurred in 3.2%, 8.1%, and 5.2% of patients at the three infrarenal levels, respectively, and in 1.7% of patients at the SR level. Similar to the multiple regression modeling for perioperative neck diameter change, multivariable regression of longer-term neck dilatation identified different predictive variables for each of the four aortic levels (Table IV) . Endograft type was associated with neck diameter changes only at level 0 and 5, where the Excluder (W. L. Gore and Associates, Flagstaff, Ariz) was associated an increase in diameter of 0.0 6 1.3 mm compared with 0.5 6 1.7 mm for the Endurant (Medtronic, Minneapolis, Minn) and 1.5 6 1.5 mm for the Zenith (Cook Medical, Bloomington, Ind) devices (Table V) .
At level 0, larger aneurysm sac diameter and longer neck length were protective against AND, whereas aortic diameter at the lowest renal artery, infrarenal angulation, and endograft oversizing were risk factors. Aortic diameter at the lowest renal artery and endograft oversizing were risk factors for AND at levels 5 and 10. At level 10, an increased number of EndoAnchors implanted was protective against AND. At level SR, the only factor predictive of AND was baseline suprarenal aortic diameter. There was no significant difference in total (preoperative to 1 year postoperative) AND between patients who underwent prophylactic implantation of EndoAnchors and patients with acute type Ia endoleaks.
DISCUSSION
If aneurysms are left untreated, the natural history of the proximal aneurysmal neck is progressive dilatation and shortening. 11 Illig et al 12 reported that significant neck dilatation developed in approximately one-third of patients who underwent OSR. The proximal aortic neck continues to enlarge even after OSR by a yearly rate of 0.16 mm at the infrarenal level and 0.18 mm at the suprarenal level. 13 This supports the theory of progressive structural deterioration of the aorta; however, only 13% of the patients in the present report exhibited a significant AND of >3 mm at a mean follow-up of 44 months. Setting a threshold of 2 mm to define AND, Oberhuber et al 14 reported an increase in diameter at the infrarenal level of 23.3% after EVAR and 19.5% after OSR (P ¼ .87) and at the SR level of 20.4% after EVAR and 30.4% after OSR (P ¼ .26). Interestingly, no significant differences were found between the dilatation rates at both levels when EVAR was compared with OSR, which raises questions regarding how much additional stress the endograft outward radial force poses to the aneurysm neck.
As long-term follow-up data of patients after EVAR accumulates, cases of AND beyond the nominal proximal diameter of the endograft are identified (Fig 1) . Despite higher rates of aneurysm-related complications and reinterventions, an increasing number of aneurysms with hostile neck anatomy are treated with EVAR. The Heli-FX EndoAnchor System was designed and introduced in recent years to stabilize and improve endograft apposition to the aortic neck to enhance fixation and seal, thereby potentially mitigating complications. Melas et al 15 reported that EndoAnchors are capable of withstanding significant displacement forces and improve endograft fixation to levels equivalent or superior to a hand-sewn surgical anastomosis in a human cadaveric model. This robust strength of fixation and seal can protect against endoleak, migration, and potentially resist proximal AND.
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The underlying pathology behind AND is considered to be a continuous degenerative process of the abdominal aorta. Biros et al 16 showed upregulation of genes connected to immunity pathways proximal to a dilated aorta. Continuous outward radial force applied to the proximal neck after endograft implantation has also been suggested as a factor contributing to AND, 17 and reports on endografts that exert minimal outward radial force at the proximal seal zone indicate stability of the neck diameter once the stent graft reaches full expansion. This appears to protect the proximal neck from dilatation as long as the stent graft is actively fixated in a sufficiently healthy aorta at the initial procedure. 18, 19 Whether a device exerts continuous significant or minimal outward radial force, the true concern with progressive AND is that it may compromise the proximal seal zone, predisposing the patient to a late type Ia endoleak, repressurization of the aortic sac, and late aneurysm rupture.
Patients with loss of proximal seal have significantly more dilated aortic neck than patients without loss of the proximal seal (4.6 6 4.5 mm vs 1.8 6 1.9 mm) and exhibit more significant endograft migration. 20 in different studies that the degree of oversizing was not correlated with AND.
The results of the present study challenge these reports. We found graft oversizing was an independent predictor for AND throughout the 10-mm zone below the lowest renal artery. Our observations are similar to those reported by Kaladji et al, 22 who measured the aortic neck diameter at different levels. They reported that graft oversizing weakly correlates with the degree of dilatation at the level of lowest renal artery, showing a mean increase of 3.7 6 2.8 mm. Our results could be interpreted as a mere consequence of higher radial forces at the seal zone but could also reflect a potential selection bias. Our patients had challenging neck anatomy that required the use of EndoAnchors preemptively (to enhance fixation and stability of the endograft in a hostile neck anatomy) or to treat a type Ia endoleak at the time of implantation, representing a cohort with a more diseased proximal neck and a higher risk of aortic complications post-EVAR. Nevertheless, the results raise questions about what the optimal degree of endograft oversizing should be when an elective repair is planned in these challenging anatomies. The concept of avoiding excessive endograft oversizing and using EndoAnchors as a means of improving seal and fixation is enticing because it could stabilize the aortic wall on the endograft and potentially prevent dilatation of the aortic neck beyond the endograft nominal diameter. Also equally attractive is the strategy of using EndoAnchors in EVAR for aneurysms with larger neck diameters, which carry a higher risk of neck dilatation and early failures, as reported by Cao et al. 23 They found preoperative neck diameter was a significant independent predictor of AND, with a hazard ratio of 1.21 for every mm of dilatation. Dillavou et al, 24 however, reported that abdominal aortic aneurysms with baseline aortic neck diameter greater than 25 mm had significantly less dilatation compared to smaller neck diameter aneurysms. Our results suggest that the diameter of the aorta at the lowest renal artery is a significant predictor for AND throughout the entire neck length. Explaining the discrepancy in these results is not easy. An enlarged aortic neck diameter may conceivably indicate more advanced degenerative changes and hence increased vulnerability to progressive dilatation. No long-term data are currently available to support the routine use of EndoAnchors in these patients; however, the results of this study provide for the first time evidence that EndoAnchors offer protection against early AND because we found that, in the first year post-EVAR, the number of EndoAnchors used was an independent predictor of a lesser degree neck dilatation 10 mm below the lowest renal artery. Ongoing patient follow-up within the ANCHOR registry could offer further validation of these early results.
This study also evaluated the type of endograft used as a contributing factor in neck dilatation post-EVAR. Although the actual numerical differences were very small (Table V) , our analysis indicated a significant difference in AND at the level of the lowest renal artery and at 5 mm infrarenal with the use of the Gore Excluder (lowest dilatation) compared with the Cook Zenith (highest dilatation) and the Medtronic Endurant endografts. This difference was not present at 10 mm below the renal arteries for the Cook graft but was present for the Medtronic Endurant graft. A possible explanation for the observed difference is that it reflects the difference in contact area of the endograft stents in the neck at the level of the lowest renal. Devices with a suprarenal bare-metal stent (Zenith and Endurant) vs those without (Excluder) account for different locations where outward radial force is exerted upon the aortic wall. A suprarenal stent design is likely associated with continuous radial force across the renal and suprarenal segment (Fig 2) .
By contrast, devices limited to the infrarenal location would not be expected to result in changes more proximally. This observation may explain why devices without a suprarenal component are associated with milder changes at or just above the renal arteries but are associated with a similar degree of dilatation more caudally.
Our results differ from previous studies that compared AND with different endografts. Dillavou et al 24 reported no significant difference in AND when endografts from various manufacturers were compared, and Pintoux et al 25 showed no difference when a graft with suprarenal fixation (Talent, Medtronic) was compared with a graft with infrarenal fixation (AneuRx, Medtronic). It should be emphasized that the current report includes patients with unfavorable neck anatomy, often outside the instructions for use of the endografts used, where EndoAnchors were deployed in each case.
Our results indicate that the more EndoAnchors deployed, the less the neck dilatation observed 12 months after EVAR. EndoAnchors appear to exert their protective effect on neck dilatation at the 10-mm level below the renal arteries. This observation can be explained by the fact that in clinical practice most EndoAnchors are deployed within 5 to 10 mm from the top of the endograft fabric, and their beneficial effect is therefore evident in that area. There is growing evidence that when devices fail to fully seal the neck, pressurized blood flow or even thrombus that runs as a blind pouch parallel to the device in the aortic neck may be associated with neck dilatation. Considering the challenging aortic neck features in the study population, our data suggest that EndoAnchors may enhance the stability of the proximal seal zone, perhaps extending the functional length of the proximal neck. Whether this effect is sustained over time to eventually prevent AND beyond the diameter of the endograft and whether the addition of EndoAnchors to EVAR will result long-term in a lower rate of aneurysm-related complications and improved outcomes remains to be proven.
This study has certain limitations that need to be taken into consideration. We did not perform a caseby-case analysis to evaluate how many of the endografts were implanted outside the instructions for use, but 76.7% of patients had at least one hostile neck characteristic as defined in the ANCHOR registry. In addition, our follow-up is limited to 1 year, and neck dilatation is a gradual process that extends beyond this time point.
Because most aortic necks, including those evaluated in this study, dilate progressively after EVAR, to claim that EndoAnchors are protective of AND appears misleading. Comparing neck dilatation in EVAR patients with EndoAnchors and a control group with matched anatomic characteristics but without EndoAnchors would provide additional insight and validity to our observations.
CONCLUSIONS
Aortic diameter and graft oversizing appear to be independent risk factors for early AND. EndoAnchors have a protective effect on neck dilatation at their usual level of deployment. 
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